- This event has passed.
October 31, 2018 @ 11:30 am - 2:00 pm
We will be hosting a luncheon, where we will be discussing “Generating IP value through Corporate Spin-Outs and other Creative Deal Structures.” More details below:
Topic: Generating IP value through Corporate Spin-Outs and other Creative Deal Structures
Abstract: Corporations invest billions of dollars in R&D, but not all of the resulting innovation aligns with the corporate strategy. Licensing or selling the resulting IP rights are common ways to generate a return on the R&D investment. However, other creative deal structures such as jointventures, or spin-outs can sometimes provide significantly higher long-term value and other additional strategic benefits, such as establishing footholds in new markets. Hear about recent transactions that included transfer of IP assets from senior executives.
Moderator: Damon Matteo, CEO Fulcrum Strategy
Stephen Freedman, Vice President for Corporate Liaison and Ventures, Gladstone Institutes
Maital Rasmussen, Head of Marketing at Roche NAVIFY Diagnostics Information
Susan Wang, Assistant General Counsel, Pfizer Inc.
Stefan Tamme, VP of IP Strategy & Licensing, Rambus Inc.